Velocity Clinical Research is a clinical research site located in Meridian, Idaho, United States 83642.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Velocity Clinical Research has participated in 15 clinical trials with 4 currently active.
Therapeutic areas: COVID-19, Early Alzheimer´s Disease, Dyslipidemias.
Sponsors: Novavax, Novo Nordisk A/S, NewAmsterdam Pharma.
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Velocity Clinical Research has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Velocity Clinical Research has 15 clinical trials on record, with 4 currently active. Their work covers COVID-19, Early Alzheimer´s Disease, Dyslipidemias.
Velocity Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.